3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gastrointestinal
1
Conditions
Stomach Neoplasms
1
Pancreatic Neoplasms
1
Gastrointestinal Stromal Tumors
1
Gallbladder Neoplasms
1
Esophageal Neoplasms
1
Duodenal Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Hepatocellular
1
Biliary Tract Neoplasms
1
Interventions
Cisplatin
5
Carboplatin
5
Cyclophosphamide
4
Bevacizumab
4
130-nm albumin-bound paclitaxel
4
pembrolizumab
3
Oxaliplatin
3
Magnetic Resonance Spectroscopy
3
Leucovorin
3
Irinotecan
3
Gemcitabine
3
Fluorouracil
3
Docetaxel
3
Capecitabine
3
tislelizumab
2
fludarabine
2
Specimen Handling
2
Riluzole
2
Quality of Life
2
Psychiatric Rehabilitation
2
Oncolytic Virotherapy
2
Observation
2
Fluorodeoxyglucose F18
2
Fluorescein
2
Floxuridine
2
Filgrastim
2
Drug Therapy
2
Cetuximab
2
umbralisib
1
trifluridine tipiracil drug combination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Stomach Neoplasms
×
Rivaroxaban
×
Sarcoma
×
Clear all
NCT03139487
2020-01-06
PRIORITY
Asan Medical Center
Phase 2
Unknown
176 enrolled